메뉴 건너뛰기




Volumn 35, Issue 3, 2010, Pages 278-281

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

Author keywords

Antibiotic; Bacteria; Subinhibitory; Travellers' diarrhoea

Indexed keywords

BACTERIAL PROTEIN; COLI SURFACE ANTIGEN 2; COLI SURFACE ANTIGEN 3; COLI SURFACE ANTIGEN 6; ENTEROTOXIN; GELATINASE B; INTERLEUKIN 8; RIFAXIMIN; UNCLASSIFIED DRUG;

EID: 73849137110     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.013     Document Type: Article
Times cited : (75)

References (15)
  • 1
    • 0037083098 scopus 로고    scopus 로고
    • Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
    • Jiang Z.D., Lowe B., Verenkar M.P., Ashley D., Steffen R., Tornieporth N., et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185 (2002) 497-502
    • (2002) J Infect Dis , vol.185 , pp. 497-502
    • Jiang, Z.D.1    Lowe, B.2    Verenkar, M.P.3    Ashley, D.4    Steffen, R.5    Tornieporth, N.6
  • 2
    • 0035576899 scopus 로고    scopus 로고
    • Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial
    • DuPont H.L., Jiang Z.D., Ericsson C.D., Adachi J.A., Mathewson J.J., DuPont M.W., et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 33 (2001) 1807-1815
    • (2001) Clin Infect Dis , vol.33 , pp. 1807-1815
    • DuPont, H.L.1    Jiang, Z.D.2    Ericsson, C.D.3    Adachi, J.A.4    Mathewson, J.J.5    DuPont, M.W.6
  • 3
    • 0035164505 scopus 로고    scopus 로고
    • In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions
    • Gomi H., Jiang Z.D., Adachi J.A., Ashley D., Lowe B., Verenkar M.P., et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 45 (2001) 212-216
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 212-216
    • Gomi, H.1    Jiang, Z.D.2    Adachi, J.A.3    Ashley, D.4    Lowe, B.5    Verenkar, M.P.6
  • 4
    • 9444286424 scopus 로고    scopus 로고
    • Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci
    • DuPont H.L., and Jiang Z.D. Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci. Clin Microbiol Infect 10 (2004) 1009-1011
    • (2004) Clin Microbiol Infect , vol.10 , pp. 1009-1011
    • DuPont, H.L.1    Jiang, Z.D.2
  • 5
    • 28044438912 scopus 로고    scopus 로고
    • Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin
    • DuPont H.L., Jiang Z.D., Okhuysen P.C., Ericsson C.D., de la Cabada F.J., Ke S., et al. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis 41 Suppl. 8 (2005) S571-S576
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 8
    • DuPont, H.L.1    Jiang, Z.D.2    Okhuysen, P.C.3    Ericsson, C.D.4    de la Cabada, F.J.5    Ke, S.6
  • 6
    • 0033943939 scopus 로고    scopus 로고
    • In vitro activity and fecal concentration of rifaximin after oral administration
    • Jiang Z.D., Ke S., Palazzini E., Riopel L., and Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother 44 (2000) 2205-2206
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 2205-2206
    • Jiang, Z.D.1    Ke, S.2    Palazzini, E.3    Riopel, L.4    Dupont, H.5
  • 7
    • 0015616521 scopus 로고
    • Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli
    • Riva S., Fietta A., Berti M., Silvestri L.G., and Romero E. Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli. Antimicrob Agents Chemother 3 (1973) 456-462
    • (1973) Antimicrob Agents Chemother , vol.3 , pp. 456-462
    • Riva, S.1    Fietta, A.2    Berti, M.3    Silvestri, L.G.4    Romero, E.5
  • 8
    • 0003344510 scopus 로고    scopus 로고
    • Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard
    • Clinical and Laboratory Standards Institute, 7th ed, Wayne, PA: CLSI
    • Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI, 2006.
    • (2006) Document
  • 9
    • 0018854046 scopus 로고
    • Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
    • Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102 (1980) 196-202
    • (1980) Anal Biochem , vol.102 , pp. 196-202
    • Heussen, C.1    Dowdle, E.B.2
  • 10
    • 2442660400 scopus 로고    scopus 로고
    • Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli
    • Huang D.B., DuPont H.L., Jiang Z.D., Carlin L., and Okhuysen P.C. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol 11 (2004) 548-551
    • (2004) Clin Diagn Lab Immunol , vol.11 , pp. 548-551
    • Huang, D.B.1    DuPont, H.L.2    Jiang, Z.D.3    Carlin, L.4    Okhuysen, P.C.5
  • 11
    • 0035694212 scopus 로고    scopus 로고
    • Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro
    • Miyajima S., Akaike T., Matsumoto K., Okamoto T., Yoshitake J., Hayashida K., et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 31 (2001) 271-281
    • (2001) Microb Pathog , vol.31 , pp. 271-281
    • Miyajima, S.1    Akaike, T.2    Matsumoto, K.3    Okamoto, T.4    Yoshitake, J.5    Hayashida, K.6
  • 12
    • 0034861026 scopus 로고    scopus 로고
    • Production of matrix metalloproteinases in response to mycobacterial infection
    • Quiding-Jarbrink M., Smith D.A., and Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 69 (2001) 5661-5670
    • (2001) Infect Immun , vol.69 , pp. 5661-5670
    • Quiding-Jarbrink, M.1    Smith, D.A.2    Bancroft, G.J.3
  • 13
    • 33748638853 scopus 로고    scopus 로고
    • Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation
    • Sorsa T., Tjäderhane L., Konttinen Y.T., Lauhio A., Salo T., Lee H.M., et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38 (2006) 306-321
    • (2006) Ann Med , vol.38 , pp. 306-321
    • Sorsa, T.1    Tjäderhane, L.2    Konttinen, Y.T.3    Lauhio, A.4    Salo, T.5    Lee, H.M.6
  • 14
    • 0023276462 scopus 로고
    • In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.
    • Ripa S., Mignini F., Prenna M., and Falcioni E. In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. Drugs Exp Clin Res 13 (1987) 483-488
    • (1987) Drugs Exp Clin Res , vol.13 , pp. 483-488
    • Ripa, S.1    Mignini, F.2    Prenna, M.3    Falcioni, E.4
  • 15
    • 33746042653 scopus 로고    scopus 로고
    • A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea
    • Taylor D.N., Bourgeois A.L., Ericsson C.D., Steffen R., Jiang Z.D., Halpern J., et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 74 (2006) 1060-1066
    • (2006) Am J Trop Med Hyg , vol.74 , pp. 1060-1066
    • Taylor, D.N.1    Bourgeois, A.L.2    Ericsson, C.D.3    Steffen, R.4    Jiang, Z.D.5    Halpern, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.